HOME > TOP STORIES
TOP STORIES
-
REGULATORY MHLW Panel to Discuss NSCLC Indication for Keytruda on Nov. 24
November 14, 2016
-
REGULATORY LDP Study Group on Biologics to Hold 1st Meeting on Nov. 24; Aims to Halt the Rush to Promote Biosimilars
November 11, 2016
-
BUSINESS Top 4 Wholesalers See Lower Sales in April-September If Hep C Meds Excluded
November 11, 2016
-
REGULATORY MHLW Plans 50% Price Cut for Opdivo
November 10, 2016
-
REGULATORY Chuikyo OKs Taltz, Micatrio for Listing on Nov. 18; Keytruda Takes Pass This Time
November 9, 2016
-
BUSINESS Current Drug Pricing System Became Unfit for New Drugs Like Opdivo: Ono Chief
November 8, 2016
-
BUSINESS MSD’s New Dual Oral Hep C Therapy to Challenge Harvoni; Effective Regardless of Resistance Mutations, Renal Impairment
November 8, 2016
-
ACADEMIA Draft Guidelines on Pneumonia Treatment Set Guides for Selecting Antibacterial Agents: Respiratory Society
November 7, 2016
-
REGULATORY PMDA Mulls Fee Raise for Drug, Device Reviews
November 4, 2016
-
REGULATORY MHLW Struggling to Set Date for Chuikyo Subcommittee Discussions on Opdivo
November 2, 2016
-
BUSINESS Strong Yen Dampens Sales of 4 Japanese Majors, but Global Brands Keep Up Momentum
November 2, 2016
-
BUSINESS Daiichi Sankyo Earnings Lower on Yen Moves; Olmesartan Suffers 21.8% Slide
November 1, 2016
-
BUSINESS Takeda’s Half-Year Sales Slip on LLP Transfer, but Profits Zoom
October 31, 2016
-
BUSINESS Public “IP Platforms” Necessary for Startups: IPSN President
October 28, 2016
-
ORGANIZATION Realtor-Led Tokyo Life Sciences Hub Initiative Aims to Fill Void between Academia, Pharmas
October 27, 2016
-
BUSINESS AZ Japan Sees Combo Holding Promise in Immuno-Oncology Race, Set to Triple Oncology Sales in 5 Years
October 26, 2016
-
BUSINESS Wholesalers Hails Gilead Ambition to Unearth More Hep C Patients through Collaboration
October 26, 2016
-
BUSINESS Ono Files Patent Infringement Suit over Keytruda
October 25, 2016
-
REGULATORY Keytruda’s November Listing Skip Likely amid Opdivo Re-Pricing Fuss
October 24, 2016
-
BUSINESS Kipres Generics Might Add Bronchial Asthma Indication before December Listing
October 21, 2016
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
